Endogenous TRAIL-R4 critically impacts apoptotic and non-apoptotic TRAIL-induced signaling in cancer cells.

Rambow, Anna-Christina; Aschenbach, Insa; Hagelund, Sofie; Tawfik, Doaa; Gundlach, Jan-Paul; Weiße, Sebastian; Maass, Nicolai; Trauzold, Anna

Rambow, Anna-Christina; Aschenbach, Insa; Hagelund, Sofie; Tawfik, Doaa; Gundlach, Jan-Paul; Weiße, Sebastian; Maass, Nicolai; Trauzold, Anna.

Afiliación

Rambow AC; Department of Gynecology and Obstetrics, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.
Aschenbach I; Institute for Experimental Cancer Research, University of Kiel, Kiel, Germany.
Hagelund S; Institute for Experimental Cancer Research, University of Kiel, Kiel, Germany.
Tawfik D; Institute for Experimental Cancer Research, University of Kiel, Kiel, Germany.
Gundlach JP; Institute for Experimental Cancer Research, University of Kiel, Kiel, Germany.
Weiße S; Institute for Experimental Cancer Research, University of Kiel, Kiel, Germany.
Maass N; Department of General Surgery, Visceral, Thoracic, Transplantation and Pediatric-Surgery, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.
Trauzold A; Institute for Experimental Cancer Research, University of Kiel, Kiel, Germany.

Front Cell Dev Biol ; 10: 942718, 2022.

Article en En | MEDLINE | ID: mdl-36158196

Palabras clave

Bcl-xL; TRAIL; TRAIL-R4; apoptosis; breast cancer; non-apoptotic signaling; pancreatic cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Cell Dev Biol Año: 2022 Tipo del documento: Article País de afiliación: Alemania